These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8230126)

  • 1. 4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
    Johnson RE; Baizman ER; Becker C; Bohnet EA; Bell RH; Birsner NC; Busacca CA; Carabateas PM; Chadwick CC; Gruett MD
    J Med Chem; 1993 Oct; 36(22):3361-70. PubMed ID: 8230126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4,5-Dihydro-3-(methanesulfonamidophenyl)-1-phenyl-1H-2,4-benzodiazepines: a novel class III antiarrhythmic agents.
    Johnson RE; Silver PJ; Becker R; Birsner NC; Bohnet EA; Briggs GM; Busacca CA; Canniff P; Carabateas PM; Chadwick CC
    J Med Chem; 1995 Jul; 38(14):2551-6. PubMed ID: 7629795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 5-cyclopropyl-1,4-benzodiazepin-2-ones as potent and selective I(Ks)-blocking class III antiarrhythmic agents.
    Butcher JW; Liverton NJ; Claremon DA; Freidinger RM; Jurkiewicz NK; Lynch JJ; Salata JJ; Wang J; Dieckhaus CM; Slaughter DE; Vyas K
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1165-8. PubMed ID: 12643935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
    Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modulation of I(Ks): potential for antiarrhythmic therapy.
    Salataa JJ; Selnickb HG; Lynch JJ
    Curr Med Chem; 2004 Jan; 11(1):29-44. PubMed ID: 14754424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
    Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS
    J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and toxicological activity of RSD921, a novel sodium channel blocker.
    Walker MJA; Hayes ES; Saint DA; Adaikan G; Abraham S; Goldin AL; Beatch GN; MacLeod BA; Wall RA; Pugsley MK
    Biomed Pharmacother; 2018 Oct; 106():510-522. PubMed ID: 29990839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of antiarrhythmic to inotropic activity and antiarrhythmic qualities of the optical isomers of verapamil.
    Raschack M
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 294(3):285-91. PubMed ID: 1004639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
    Lynch JJ; Wallace AA; Van der Gaag LH; Baskin EP; Bear CM; Gehret JR; Kothstein T; Stupienski RF; Appleby SD; Sanguinetti MC
    J Pharmacol Exp Ther; 1993 May; 265(2):720-30. PubMed ID: 8496818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments.
    Kohajda Z; Farkas-Morvay N; Jost N; Nagy N; Geramipour A; Horváth A; Varga RS; Hornyik T; Corici C; Acsai K; Horváth B; Prorok J; Ördög B; Déri S; Tóth D; Levijoki J; Pollesello P; Koskelainen T; Otsomaa L; Tóth A; Baczkó I; Leprán I; Nánási PP; Papp JG; Varró A; Virág L
    PLoS One; 2016; 11(11):e0166041. PubMed ID: 27832106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 5-aminoacyl-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-ones with antiarrhythmic activity.
    Poppe H; Kaverina NV; Lyskovzev VV; Egerland U; Sauer W; Lichoscherstow A; Rüger C; Skoldinow A
    Pharmazie; 1997 Nov; 52(11):821-30. PubMed ID: 9399338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiarrhythmic activity of 2,5-disubstituted 2,3-dihydro-1,2,5-benzothiadiazepin-4(5H)-one 1,1-dioxides.
    Ogawa K; Matsushita Y
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2442-7. PubMed ID: 1446366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds. 2.
    Lis R; Davey DD; Morgan TK; Lumma WC; Wohl RA; Jain VK; Wan CN; Argentieri TM; Sullivan ME; Cantor EH
    J Med Chem; 1987 Dec; 30(12):2303-9. PubMed ID: 3681900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-[(omega-amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activity.
    Hester JB; Gibson JK; Cimini MG; Emmert DE; Locker PK; Perricone SC; Skaletzky LL; Sykes JK; West BE
    J Med Chem; 1991 Jan; 34(1):308-15. PubMed ID: 1992131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of the anxiolytic compound metaclazepam in comparison to other benzodiazepines.
    Buschmann G; Kühl UG; Rohte O
    Arzneimittelforschung; 1985; 35(11):1643-55. PubMed ID: 2868732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro antiarrhythmic effects of SSR149744C in animal models of atrial fibrillation and ventricular arrhythmias.
    Gautier P; Serre M; Cosnier-Pucheu S; Djandjighian L; Roccon A; Herbert JM; Nisato D
    J Cardiovasc Pharmacol; 2005 Feb; 45(2):125-35. PubMed ID: 15654261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Example of dose finding in practice. Pharmacology of an antiarrhythmic agent (author's transl)].
    Oberdorf A; Raschack M
    Arzneimittelforschung; 1977 Feb; 27(2A):281-3. PubMed ID: 577176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
    Osadchii OE
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):489-500. PubMed ID: 22918600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.
    Gwilt M; Arrowsmith JE; Blackburn KJ; Burges RA; Cross PE; Dalrymple HW; Higgins AJ
    J Pharmacol Exp Ther; 1991 Jan; 256(1):318-24. PubMed ID: 1988662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic effects of two new propafenone related drugs. A study on four animal models of arrhythmia.
    Wascher TC; Dittrich P; Kukovetz WR
    Arzneimittelforschung; 1991 Feb; 41(2):119-24. PubMed ID: 2043172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.